CERTARA INC (CERT) Stock Price, Quote, News and Overview
NASDAQ:CERT - Nasdaq - US15687V1098 - Common Stock - Currency: USD
CERT Quote, Performance and Key Statistics
CERTARA INC
NASDAQ:CERT (2/4/2025, 8:00:00 PM)
After market: 13.85 -0.01 (-0.07%)13.86
-0.12 (-0.86%)
The current stock price of CERT is 13.86 USD. In the past month the price increased by 23.64%. In the past year, price decreased by -19.56%.
CERT Latest News, Press Releases and Analysis
Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences
RADNOR, Pa., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it...
Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results
Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results
Full-Year 2024 Revenue of $384.4 million, Bookings of $445.3 millionConfirms Adjusted EBITDA within Guidance Range of $120 million to $124 million ...
Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
RADNOR, Pa., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that...
CERT Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 37.34 | 37.89B | ||
| DOCS | DOXIMITY INC-CLASS A | 52.46 | 10.97B | ||
| WAY | WAYSTAR HOLDING CORP | N/A | 7.07B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 15.06 | 1.84B | ||
| SDGR | SCHRODINGER INC | N/A | 1.82B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.79B | ||
| PHR | PHREESIA INC | N/A | 1.67B | ||
| EVH | EVOLENT HEALTH INC - A | 11.26 | 1.19B | ||
| HSTM | HEALTHSTREAM INC | 51.28 | 1.01B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 965.28M | ||
| DH | DEFINITIVE HEALTHCARE CORP | 15.15 | 798.15M | ||
| SLP | SIMULATIONS PLUS INC | 88.75 | 713.20M |
Related stock screener links
About CERT
Company Profile
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. The company is headquartered in Radnor, Pennsylvania and currently employs 1,338 full-time employees. The company went IPO on 2020-12-11. The firm accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. The company delivers software products and technology-driven services to customers to efficiently carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services are underpinned by technologies such as regulatory submissions software, natural language processing and Bayesian analytics. The company also develops scientific informatics software products used by the life sciences industry for in-silico research. The company develops advanced modeling and biosimulation solutions used to predict the pharmacokinetic and pharmacodynamic properties. Its clients include 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 66 countries.
Company Info
CERTARA INC
4 Radnor Corporate Center, Suite 350
Radnor PENNSYLVANIA 08540 US
CEO: William F. Feehery
Employees: 1365
Company Website: https://www.certara.com/
Investor Relations: https://ir.certara.com/
Phone: 14152378272
CERT FAQ
What is the stock price of CERT?
The current stock price of CERT is 13.86 USD.
What is the symbol for CERTARA INC stock?
The exchange symbol of CERTARA INC is CERT and it is listed on the Nasdaq exchange.
On which exchange is CERT stock listed?
CERT stock is listed on the Nasdaq exchange.
Is CERT a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for CERT, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of CERT.
Does CERT stock pay dividends?
CERT does not pay a dividend.
When does CERT stock report earnings?
CERT will report earnings on 2025-02-26, after the market close.
What is the Price/Earnings (PE) ratio of CERT?
The PE ratio for CERT is 35.54. This is based on the reported non-GAAP earnings per share of 0.39 and the current share price of 13.86 USD.
What is the Short Interest ratio of CERT stock?
The outstanding short interest for CERT is 3.68% of its float.
CERT Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to CERT. When comparing the yearly performance of all stocks, CERT turns out to be only a medium performer in the overall market: it outperformed 54.35% of all stocks.
CERT Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CERT. The financial health of CERT is average, but there are quite some concerns on its profitability.
CERT Financial Highlights
Over the last trailing twelve months CERT reported a non-GAAP Earnings per Share(EPS) of 0.39. The EPS increased by -23.53% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.01% | ||
| ROE | -2.95% | ||
| Debt/Equity | 0.28 |
CERT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 75% to CERT. The Buy consensus is the average rating of analysts ratings from 17 analysts.
For the next year, analysts expect an EPS growth of -0.76% and a revenue growth 8.55% for CERT